ISL
CEMI

Ingalls & Snyder LLC’s Chembio diagnostics, Inc. CEMI Stock Holding History

Ingalls & Snyder LLC’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-266,473
Closed -$1.36M – 442
2020
Q1 		$1.36M Sell
266,473
-42,771
-14% -$173K 0.09% 154
2019
Q4 		$1.41M Buy
309,244
+6,000
+2% +$29.2K 0.08% 165
2019
Q3 		$1.86M Buy
303,244
+5,167
+2% +$30.8K 0.09% 159
2019
Q2 		$1.81M Sell
298,077
-1,500
-0.5% -$10.1K 0.09% 165
2019
Q1 		$1.66M Sell
299,577
-18,062
-6% -$117K 0.08% 173
2018
Q4 		$1.8M Buy
317,639
+13,271
+4% +$97.8K 0.09% 159
2018
Q3 		$3.2M Buy
+304,368
New +$3.27M 0.13% 125

Other funds holding CEMI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ingalls & Snyder LLC's CEMI Position: Q2 2020 in Review

Ingalls & Snyder LLC sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 266,473 shares — an estimated $1.36M sold.

Ingalls & Snyder LLC first reported a position in CEMI in Q3 2018 and held it in 7 quarters. The position peaked at $3.2M in Q3 2018. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

  • Ingalls & Snyder LLC reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 266,473 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $1.36M.
  • Ingalls & Snyder LLC first reported a position in Chembio diagnostics, Inc. in Q3 2018 and held it in 7 quarters.
  • Ingalls & Snyder LLC's Chembio diagnostics, Inc. position peaked at $3.2M in Q3 2018.
  • 76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2020, filed 31 Jul 2020.